Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whether NAFLD is a risk factor for the development of sarcopenia is not clear. We investigated relationships between NAFLD and low skeletal muscle mass index (LSMI) using three different datasets. Participants were classified into LSMI and normal groups. LSMI was defined as a body mass index (BMI)-adjusted appendicular skeletal muscle mass <0.789 in men and <0.512 in women or as the sex-specific lowest quintile of BMI-adjusted total skeletal muscle mass. NAFLD was determined according to NAFLD liver fat score or abdominal ultrasonography. The NAFLD groups showed a higher hazard ratios (HRs) with 95% confidence intervals (CIs) for LSMI than the no...
Table A1. Incidence of LSMI during the follow-up study. Table A2. HR and 95% CI for incident LSMI pe...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
Aim. Previous studies have shown that individuals with low muscle mass exhibit an increased risk of ...
International audienceAn extensive body of the literature shows a strong interrelationship between t...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steato hepatitis have an increasing preval...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it i...
Sarcopenia is known to be associated with non-alcoholic fatty liver disease (NAFLD). However, few st...
Background Sarcopenia recognises insulin resistance and obesity as risk factors, and is frequently ...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
Table A1. Incidence of LSMI during the follow-up study. Table A2. HR and 95% CI for incident LSMI pe...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
Aim. Previous studies have shown that individuals with low muscle mass exhibit an increased risk of ...
International audienceAn extensive body of the literature shows a strong interrelationship between t...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steato hepatitis have an increasing preval...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it i...
Sarcopenia is known to be associated with non-alcoholic fatty liver disease (NAFLD). However, few st...
Background Sarcopenia recognises insulin resistance and obesity as risk factors, and is frequently ...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
Table A1. Incidence of LSMI during the follow-up study. Table A2. HR and 95% CI for incident LSMI pe...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...